Jan-Feb 2008
Palladium/Tetraphosphine Catalyzed Suzuki Cross-Couplilng of Heteroarylboronic Acids
117
3-o-Tolylfuran (26). (Table 5, entry 10) 2-Bromotoluene
(171 mg, 1 mmol), 3-furanboronic acid (224 mg, 2 mmol),
K2CO3 (276 mg, 2 mmol), xylene (3 mL), Tedicyp-palladium
complexe (33 μmol) gave 33 in 75% (116 mg) isolated yield. 1H
nmr (300 MHz, CDCl3): ꢀ = 7.33–7.42 (m, 2H), 7.48 (t, J = 7.1
Hz, 2H), 7.58 (d, J = 7.1 Hz, 2H), 7.87 (dt, J = 8.0, 1.9 Hz, 1H),
8.58 (dd, J = 4.7, 1.9 Hz, 1H), 8.84 (d, J = 2.2 Hz, 1H).
1
complexe (4 μmol) gave 26 in 81% (128 mg) isolated yield. H
nmr (300 MHz, CDCl3): ꢀ = 2.38 (s, 3H), 6.58 (dd, J = 1.7, 0.9
Hz, 1H), 7.17–7.35 (m, 4H), 7.47 (t, J = 1.7 Hz, 1H), 7.52 (d, J =
0.9 Hz, 1H).
Phenyl-(4-pyridin-3-yl-phenyl)-methanone (34). (Table 7,
entry 3) 4-Bromobenzophenone (261 mg, 1 mmol), 3-pyridine-
boronic acid (246 mg, 2 mmol), K2CO3 (276 mg, 2 mmol),
xylene (3 mL), Tedicyp-palladium complexe (50 μmol) gave 34
1-(4-Benzofuran-2-yl-phenyl)-ethanone (27).
(Table 6,
1
entry 1) 4-Bromoacetophenone (199 mg, 1 mmol), 2-benzo-
furanboronic acid (324 mg, 2 mmol), K2CO3 (276 mg, 2 mmol),
xylene (3 mL), Tedicyp-palladium complexe (50 μmol) gave 27
in 82% (210 mg) isolated yield. H nmr (300 MHz, CDCl3): ꢀ =
7.45 (dd, J = 7.9, 4.9 Hz, 1H), 7.54 (t, J = 7.1 Hz, 2H), 7.63 (t, J
= 7.1 Hz, 1H), 7.75 (d, J = 8.4 Hz, 2H), 7.88 (d, J = 8.4 Hz, 2H),
7.93–8.03 (m, 3H), 8.70 (dd, 1H, J = 4.8, 1.8 Hz, 1H), 8.95 (d, J
= 1.8 Hz, 1H).
1
in 66% (156 mg) isolated yield. H nmr (300 MHz, CDCl3): ꢀ =
2.62 (s, 3H), 7.15 (s, 1H), 7.27 (td, J = 7.8, 1.2 Hz, 1H), 7.33 (td,
J = 7.8, 1.2 Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 7.8
Hz, 1H), 7.93 (d, J = 8.4 Hz, 2H), 8.03 (d, J = 8.4 Hz, 2H).
4-Benzofuran-2-yl-benzaldehyde (28). (Table 6, entry 2)
4-Bromobenzaldehyde (185 mg, 1 mmol), 2-benzofuranboronic
acid (324 mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3
mL), Tedicyp-palladium complexe (10 μmol) gave 28 in 95%
(211 mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 7.19 (s,
1H), 7.28 (td, J = 7.8, 1.5 Hz, 1H), 7.32 (td, J = 7.8, 1.5 Hz, 1H),
7.52 (d, J = 7.8 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.92 (d, J =
8.4 Hz, 2H), 8.01 (d, J = 8.4 Hz, 2H), 10.02 (s, 1H).
3-Pyridin-3-yl-benzaldehyde (35). (Table 7, entry 4)
3-Bromobenzaldehyde (185 mg, 1 mmol), 3-pyridineboronic
acid (246 mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3
mL), Tedicyp-palladium complexe (50 μmol) gave 35 in 84%
1
(174 mg) isolated yield. H nmr (300 MHz, CDCl3): ꢀ = 7.42
(dd, J = 7.6, 4.9 Hz, 1H), 7.66 (t, J = 7.8 Hz, 1H), 7.85 (dt, J =
7.6, 1.0 Hz, 1H), 7.93 (dd, J = 7.8, 1.3 Hz, 2H), 8.08 (s, 1H),
8.64 (bs, 1H), 8.89 (bs, 1H), 10.09 (s, 1H).
3-(4-Fluorophenyl)-pyridine (36).
(Table 7, entry 6)
4-Fluorobromobenzene (175 mg, 1 mmol), 3-pyridineboronic
acid (246 mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3
mL), Tedicyp-palladium complexe (100 μmol) gave 36 in 84%
(4-Benzofuran-2-yl-phenyl)-phenylmethanone (29).
(Table 6, entry 4) 4-Bromobenzophenone (261 mg, 1 mmol),
2-benzofuranboronic acid (324 mg, 2 mmol), K2CO3 (276 mg, 2
mmol), xylene (3 mL), Tedicyp-palladium complexe (50 μmol)
1
(145 mg) isolated yield. H nmr (300 MHz, CDCl3): ꢀ = 7.14
(dd, J = 8.8, 8.6 Hz, 2H), 7.35 (dd, J = 7.7, 4.9 Hz, 1H), 7.54
(dd, J = 8.8, 5.3 Hz, 2H), 7.83 (dt, J = 7.7, 1.4 Hz, 1H), 8.59 (bs,
1H), 8.81 (bs, 1H).
1
gave 29 in 85% (253 mg) isolated yield. H nmr (300 MHz,
CDCl3): ꢀ = 7.18 (d, J = 0.8 Hz, 1H), 7.26 (td, J = 8.0, 1.3 Hz,
1H), 7.33 (td, J = 8.0, 1.3 Hz, 1H), 7.46–7.64 (m, 5H), 7.82 (dd,
J = 7.0, 1.3 Hz, 2H), 7.90 (d, J = 8.6 Hz, 2H), 7.97 (d, J = 8.6
Hz, 2H). 13C nmr (300 MHz, CDCl3): ꢀ = 103.5, 111.4, 121.3,
123.2, 124.5, 125.1, 128.3, 128.9, 129.9, 130.7, 132.5, 134.1,
137.0, 137.6, 154.6, 155.2, 195.9. MS (EI, 70 eV): m/z (%) =
298 (100) [M+]. Anal. Calcd. For C21H14O2: C, 84.54; H, 4.73,
found C, 84.38; H, 4.84. White solid mp = 192 °C.
4-Benzofuran-2-ylbenzonitrile (30). (Table 6, entry 5)
4-Bromobenzonitrile (182 mg, 1 mmol), 2-benzofuranboronic
acid (324 mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3
mL), Tedicyp-palladium complexe (50 μmol) gave 30 in 88%
(193 mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 7.16 (s,
1H), 7.26 (td, J = 7.8, 1.3 Hz, 1H), 7.34 (td, J = 7.8, 1.3 Hz, 1H),
7.53 (d, J = 7.9 Hz, 1H), 7.61 (d, J = 7.9 Hz, 1H), 7.71 (d, J =
8.6 Hz, 2H), 7.94 (d, J = 8.6 Hz, 2H).
2-(4-Methoxyphenyl)-benzofuran (31). (Table 6, entry 7)
4-Bromoanisole (187 mg, 1 mmol), 2-benzofuranboronic acid
(324 mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3 mL),
Tedicyp-palladium complexe (50 μmol) gave 31 in 62% (139
mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 3.85 (s, 3H),
6.88 (s, 1H), 6.97 (d, J = 9.0 Hz, 2H), 7.17–7.25 (m, 2H), 7.49
(dd, J = 7.4, 1.1 Hz, 1H), 7.55 (dd, J = 7.4, 1.1 Hz, 1H), 7.79 (d,
J = 9.0 Hz, 2H).
3-(4-Methoxyphenyl)-pyridine (37). (Table 7, entry 8)
4-Bromoanisole (187 mg, 1 mmol), 3-pyridineboronic acid (246
mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3 mL),
Tedicyp-palladium complexe (50 μmol) gave 37 in 80% (148
mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 3.85 (s, 3H),
7.00 (d, J = 8.9 Hz, 2H), 7.35 (dd, J = 7.5, 4.7 Hz, 1H), 7.50 (d, J
= 8.9 Hz, 2H), 7.82 (dt, J = 7.5, 1.5 Hz, 1H), 8.54 (dd, J = 4.7,
1.5 Hz, 1H), 8.80 (d, J = 1.5 Hz, 1H).
1-(2-Pyridin-3-ylphenyl)-ethanone (38). (Table 7, entry 10)
2-Bromoacetophenone (199 mg, 1 mmol), 3-pyridineboronic
acid (246 mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3
mL), Tedicyp-palladium complexe (50 μmol) gave 38 in 80%
(147 mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 2.19 (s,
3H), 7.32–7.38 (m, 2H), 7.47 (td, J = 7.6, 1.3 Hz, 1H), 7.55 (td, J
= 7.6, 1.5 Hz, 1H), 7.62–7.68 (m, 2H), 8.58 (bs, 1H), 8.62 (d, J =
3.4 Hz, 1H).
3-(2-Methoxyphenyl)pyridine (39). (Table 7, entry 13)
2-Bromoanisole (187 mg, 1 mmol), 3-pyridineboronic acid (246
mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3 mL),
Tedicyp-palladium complexe (100 μmol) gave 39 in 61% (113
mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 3.81 (s, 3H),
6.67–7.10 (m, 2H), 7.30–7.40 (m, 3H), 7.85 (dt, J = 8.0, 2.1 Hz,
1H), 8.54 (d, J = 3.7 Hz, 1H), 8.76 (bs, 1H).
2-o-Tolylbenzofuran (32). (Table 6, entry 9) 2-Bromo-
toluene (171 mg, 1 mmol), 2-benzofuranboronic acid (324 mg, 2
mmol), K2CO3 (276 mg, 2 mmol), xylene (3 mL), Tedicyp-
palladium complexe (50 μmol) gave 32 in 75% (156 mg)
isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 2.58 (s, 3H), 6.89
(s, 1H), 7.24–7.35 (m, 5H), 7.52 (dd, J = 7.2, 1.0 Hz, 1H), 7.61
(dd, J = 7.2, 1.0 Hz, 1H), 7.85 (m, 1H).
3-Phenylpyridine (33). (Table 7, entry 1) Bromobenzene
(157 mg, 1 mmol), 3-pyridineboronic acid (246 mg, 2 mmol),
K2CO3 (276 mg, 2 mmol), xylene (3 mL), Tedicyp-palladium
3-(2-Methylphenyl)pyridine (40).
(Table 7, entry 14)
2-Bromotoluene (171 mg, 1 mmol), 3-pyridineboronic acid (246
mg, 2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3 mL),
Tedicyp-palladium complexe (50 μmol) gave 40 in 85% (144
mg) isolated yield. 1H nmr (300 MHz, CDCl3): ꢀ = 2.27 (s, 3H),
7.18–7.31 (m, 4H), 7.34 (dd, J = 7.8, 4.8 Hz, 1H), 7.65 (dt, J =
7.8, 1.9 Hz, 1H), 8.56 (dd, J = 4.8, 1.9 Hz, 1H), 8.59 (s, 1H).
3-(1-Naphthyl)pyridine (41). (Table 7, entry 16) 1-Bromo-
naphthalene (207 mg, 1 mmol), 3-pyridineboronic acid (246 mg,
2 mmol), K2CO3 (276 mg, 2 mmol), xylene (3 mL), Tedicyp-